Biblio
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease. N Engl J Med. 2021;385(3):228-238.
Natural history of EBV replication and viral load dynamics after alemtuzumab based allogeneic stem cell transplantation. Transplant Cell Ther. 2021.
. Graft-versus-host disease reduces lymph node display of tissue-restricted self-antigens and promotes autoimmunity. J Clin Invest. 2020.
. G-CSF mobilizes CD34+ regulatory monocytes that inhibit graft-versus-host disease. Sci Transl Med. 2015;7(281):281ra42.